Abs+
Abs+, licence 80018883: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80018883
- Status
- Active licence
- Licence date
- 20 May 2010
- Revision date
- 11 March 2019
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide linoléique conjugué Source : Acide linoléique conjugué Potency : 80.0 % CLA | 582.4 mg | Not calculated |
Non-medicinal ingredients
Carob, Lécithine, Cire d'abeille, Caramel, Glycérine, Gélatine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
May help to support a modest reduction in fat mass when used with a program of reduced intake of dietary calories and increased physical activity. May help to support a modest improvement to body composition when used with a program of reduced intake of dietary calories and increased physical activity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, if your goal is to achieve weight loss, if you are obese or have cardiovascular disease (CVD) risk factors, have a liver disorder, an iron deficiency or for use beyond 12 weeks. Do not use if you have CVD, diabetes, metabolic syndrome or insulin resistance. Some people may experience gastrointestinal upset. Stop use and consult a health care practitioner if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite.
Source
Official Health Canada record, licence 80018883
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.